跳至主要内容
临床试验/NCT06724250
NCT06724250已完成4 期

Biofeedback Versus Botox Injection in Treatment of Dyssynergic Defecation (Randomized Controlled Trial)

Mansoura University1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
78
试验地点
1
主要终点
Improvement of symptoms of constipation for one year follow up

研究概览

简要总结

assessment the Improvement symptoms of obstructed defecation after biofeedback training versus botulinum toxin injection

详细描述

This is a randomized controlled trial including 78 patients diagnosed with obstructed defecation syndrome confirmed by detailed history talking, full clinical examination, anorectal manometry and defecography.

Included patients divided into two equal groups: first group ( biofeedback therapy group) patients recieved biofeedback therapy for six sessions over one month, the second group:( botulinum toxin group) received botulinum toxin injection 100 IU in buborectalis muscle.

The primary outcome is improvement of symptoms after one year

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients of both genders
  • •age of 18 years or older
  • •fulfillment of the Rome 3 constipation criteria for the past 3 months, symptom onset as a maximum six months prior to diagnosis, patients suffer from prolonged, incomplete and challenging evacuation

排除标准

  • •Anismus cases with secondary reason for constipation
  • •patients who undergone anorectal surgery Patients with colonic inertia
  • •conditions that make biofeedback training impossible
  • •cases with primary illness causing constipation as hypothyroidism

研究组 & 干预措施

Biofeedback therapy group

Active Comparator

Patients with dyssynergic defecation underwent biofeedback training program in the form of six sessions over one month

干预措施: Biofeedback therapy (Device)

Botox injection group

Active Comparator

Participants in this group received 100 international unit of botulinum toxin type A that was injected injections into the puborectalis muscle to alleviate dyssynergic defecation by reducing muscle overactivity and improving coordination.

干预措施: Botulinum Toxin A (Botox ) (Drug)

结局指标

主要结局

Improvement of symptoms of constipation for one year follow up

时间窗: One year

* Follow-up was conducted for about 1 year as regard the improvement in bowel habits. * Patients was asked to fill up a symptom questionnaire (Wexner constipation score with a maximum score of 30 and a minimum of 0) following the therapeutic procedure The wexner constipation score : include 8-item questionnaire about bowel movements frequency, anal pain during evacuation, abdominal pain, incomplete evacuation, time taken for evacuation per attempt, number of attempts for a successful bowel movement in the previous 24 hours, type of assistance for defecation, and duration of constipation. All items are scored from 0 to 4 except for the "type of assistance for defecation," which is scored from 0 to 2.The clinical improvement was chosen when there was decrease in the score.

次要结局

  • Improvement of pain for one year follow up(One year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验